Status Unknown
Blood-based Biomarkers for Early Alzheimers Disease Screening
Led by Peking University First Hospital · Updated on 2024-06-27
180
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
The goal of this observational study is to estimate the screen performance of blood biomarkers of interest (Aβ40 and Aβ42, P-Tau181, P-Tau217, GFAP and NfL) in patients with Alzheimer's disease (AD), mild cognitive impairment due to AD, and cognitively normal individuals. The main questions it aims to answer are: * to identify core blood biomarker suitable for early screening of AD. * to establish a comprehensive model for the early identification of AD.
CONDITIONS
Brief Title
Blood Biomarkers for Screening of Alzheimer's Disease
Research Team
C
Chen Zhang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here